1.
Rheumatol Int
; 31(3): 405-7, 2011 Mar.
Article
in English
| MEDLINE
| ID: mdl-19834709
ABSTRACT
Macrophage activation syndrome (MAS) is a disorder characterized by increased activation of mononuclear cells leading to phagocytosis of blood cell precursors in the bone marrow. We describe a case of MAS triggered by disseminated histoplasmosis occurring in a patient with Still's disease on long-term treatment with adalimumab.